The World Health Organization has issued a global safety alert over rare cases of irreversible vision loss linked to popular diabetes and weight-loss drugs containing semaglutide, including Ozempic, Rybelsus, and Wegovy. Patients experiencing sudden vision loss are urged to seek immediate medical help, and healthcare providers are advised to discuss the potential risk with patients.